Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 800

1.

SUMO pathway inhibition targets an aggressive pancreatic cancer subtype.

Biederstädt A, Hassan Z, Schneeweis C, Schick M, Schneider L, Muckenhuber A, Hong Y, Siegers G, Nilsson L, Wirth M, Dantes Z, Steiger K, Schunck K, Langston S, Lenhof HP, Coluccio A, Orben F, Slawska J, Scherger A, Saur D, Müller S, Rad R, Weichert W, Nilsson J, Reichert M, Schneider G, Keller U.

Gut. 2020 Jan 30. pii: gutjnl-2018-317856. doi: 10.1136/gutjnl-2018-317856. [Epub ahead of print]

2.

First validation of a novel assessgame quantifying selective voluntary motor control in children with upper motor neuron lesions.

Keller JW, Balzer J, Fahr A, Lieber J, Keller U, van Hedel HJA.

Sci Rep. 2019 Dec 30;9(1):19972. doi: 10.1038/s41598-019-56495-8.

3.

Calibration of high-accuracy spectrometers using stabilized 11-GHz femtosecond semiconductor laser.

Jallageas A, Nürnberg J, Alfieri CGE, Waldburger D, Link SM, Emaury F, Morel J, Keller U.

Opt Express. 2019 Dec 23;27(26):37552-37558. doi: 10.1364/OE.27.037552.

PMID:
31878534
4.

Power-scaling of nonlinear-mirror modelocked thin-disk lasers.

Graumann IJ, Saltarelli F, Lang L, Wittwer VJ, Südmeyer T, Phillips CR, Keller U.

Opt Express. 2019 Dec 23;27(26):37349-37363. doi: 10.1364/OE.27.037349.

PMID:
31878517
5.

Four versus six cycles of CHOP chemotherapy in combination with six applications of rituximab in patients with aggressive B-cell lymphoma with favourable prognosis (FLYER): a randomised, phase 3, non-inferiority trial.

Poeschel V, Held G, Ziepert M, Witzens-Harig M, Holte H, Thurner L, Borchmann P, Viardot A, Soekler M, Keller U, Schmidt C, Truemper L, Mahlberg R, Marks R, Hoeffkes HG, Metzner B, Dierlamm J, Frickhofen N, Haenel M, Neubauer A, Kneba M, Merli F, Tucci A, de Nully Brown P, Federico M, Lengfelder E, di Rocco A, Trappe R, Rosenwald A, Berdel C, Maisenhoelder M, Shpilberg O, Amam J, Christofyllakis K, Hartmann F, Murawski N, Stilgenbauer S, Nickelsen M, Wulf G, Glass B, Schmitz N, Altmann B, Loeffler M, Pfreundschuh M; FLYER Trial Investigators; German Lymphoma Alliance.

Lancet. 2020 Dec 21;394(10216):2271-2281. doi: 10.1016/S0140-6736(19)33008-9.

PMID:
31868632
6.

Tyrphostin AG490 reduces inflammation and fibrosis in neonatal obstructive nephropathy.

Gasparitsch M, Schieber A, Schaubeck T, Keller U, Cattaruzza M, Lange-Sperandio B.

PLoS One. 2019 Dec 17;14(12):e0226675. doi: 10.1371/journal.pone.0226675. eCollection 2019.

7.

Neonatal obstructive nephropathy induces necroptosis and necroinflammation.

Popper B, Rammer MT, Gasparitsch M, Singer T, Keller U, Döring Y, Lange-Sperandio B.

Sci Rep. 2019 Dec 9;9(1):18600. doi: 10.1038/s41598-019-55079-w.

8.

Sub-cycle time resolution of multi-photon momentum transfer in strong-field ionization.

Willenberg B, Maurer J, Mayer BW, Keller U.

Nat Commun. 2019 Dec 5;10(1):5548. doi: 10.1038/s41467-019-13409-6.

9.

Rituximab With Involved Field Irradiation for Early-stage Nodal Follicular Lymphoma: Results of the MIR Study.

Herfarth K, Borchmann P, Schnaidt S, Hohloch K, Budach V, Engelhard M, Viardot A, Engenhart-Cabillic R, Keller U, Reinartz G, Eich HT, Witzens-Harig M, Hess CF, Dörken B, Dürig J, Wiegel T, Hiddemann W, Hoster E, Pott C, Dreyling M.

Hemasphere. 2018 Nov 30;2(6):e160. doi: 10.1097/HS9.0000000000000160. eCollection 2018 Dec.

10.

Power scaling of ultrafast oscillators: 350-W average-power sub-picosecond thin-disk laser.

Saltarelli F, Graumann IJ, Lang L, Bauer D, Phillips CR, Keller U.

Opt Express. 2019 Oct 28;27(22):31465-31474. doi: 10.1364/OE.27.031465.

PMID:
31684382
11.

The SUMO Isopeptidase SENP6 Functions as a Rheostat of Chromatin Residency in Genome Maintenance and Chromosome Dynamics.

Wagner K, Kunz K, Piller T, Tascher G, Hölper S, Stehmeier P, Keiten-Schmitz J, Schick M, Keller U, Müller S.

Cell Rep. 2019 Oct 8;29(2):480-494.e5. doi: 10.1016/j.celrep.2019.08.106.

12.

Age-Related Gliosis Promotes Central Nervous System Lymphoma through CCL19-Mediated Tumor Cell Retention.

O'Connor T, Zhou X, Kosla J, Adili A, Garcia Beccaria M, Kotsiliti E, Pfister D, Johlke AL, Sinha A, Sankowski R, Schick M, Lewis R, Dokalis N, Seubert B, Höchst B, Inverso D, Heide D, Zhang W, Weihrich P, Manske K, Wohlleber D, Anton M, Hoellein A, Seleznik G, Bremer J, Bleul S, Augustin HG, Scherer F, Koedel U, Weber A, Protzer U, Förster R, Wirth T, Aguzzi A, Meissner F, Prinz M, Baumann B, Höpken UE, Knolle PA, von Baumgarten L, Keller U, Heikenwalder M.

Cancer Cell. 2019 Sep 16;36(3):250-267.e9. doi: 10.1016/j.ccell.2019.08.001.

PMID:
31526758
13.

Phase stabilization of an attosecond beamline combining two IR colors.

Schlaepfer F, Volkov M, Hartmann N, Niedermayr A, Schumacher Z, Gallmann L, Keller U.

Opt Express. 2019 Aug 5;27(16):22385-22392. doi: 10.1364/OE.27.022385.

PMID:
31510533
14.

Positron Emission Tomography-Guided Treatment in Early-Stage Favorable Hodgkin Lymphoma: Final Results of the International, Randomized Phase III HD16 Trial by the German Hodgkin Study Group.

Fuchs M, Goergen H, Kobe C, Kuhnert G, Lohri A, Greil R, Sasse S, Topp MS, Schäfer E, Hertenstein B, Soekler M, Vogelhuber M, Zijlstra JM, Keller UB, Krause SW, Wilhelm M, Maschmeyer G, Thiemer J, Dührsen U, Meissner J, Viardot A, Eich H, Baues C, Diehl V, Rosenwald A, von Tresckow B, Dietlein M, Borchmann P, Engert A.

J Clin Oncol. 2019 Nov 1;37(31):2835-2845. doi: 10.1200/JCO.19.00964. Epub 2019 Sep 10.

PMID:
31498753
15.

Ultrafast nuclear dynamics of the acetylene cation C2H2+ and its impact on the infrared probe pulse induced C-H bond breaking efficiency.

Hartmann N, Bhattacharyya S, Schlaepfer F, Volkov M, Schumacher Z, Lucchini M, Gallmann L, Rothlisberger U, Keller U.

Phys Chem Chem Phys. 2019 Aug 21;21(33):18380-18385. doi: 10.1039/c9cp03138c.

PMID:
31403645
16.

Activated gp130 signaling selectively targets B cell differentiation to induce mature lymphoma and plasmacytoma.

Scherger AK, Al-Maarri M, Maurer HC, Schick M, Maurer S, Öllinger R, Gonzalez-Menendez I, Martella M, Thaler M, Pechloff K, Steiger K, Sander S, Ruland J, Rad R, Quintanilla-Martinez L, Wunderlich FT, Rose-John S, Keller U.

JCI Insight. 2019 Aug 8;4(15). pii: 128435. doi: 10.1172/jci.insight.128435. eCollection 2019 Aug 8.

17.

Towards quantitative imaging biomarkers of tumor dissemination: A multi-scale parametric modeling of multiple myeloma.

Piraud M, Wennmann M, Kintzelé L, Hillengass J, Keller U, Langs G, Weber MA, Menze BH.

Med Image Anal. 2019 Oct;57:214-225. doi: 10.1016/j.media.2019.07.001. Epub 2019 Jul 4.

PMID:
31349146
18.

Nutritional Laboratory Markers in Malnutrition.

Keller U.

J Clin Med. 2019 May 31;8(6). pii: E775. doi: 10.3390/jcm8060775. Review.

19.

Reduction of laser-intensity-correlated noise in high-harmonic generation.

Volkov M, Pupeikis J, Phillips CR, Schlaepfer F, Gallmann L, Keller U.

Opt Express. 2019 Mar 18;27(6):7886-7895. doi: 10.1364/OE.27.007886.

PMID:
31052615
20.

MDM4 Is Targeted by 1q Gain and Drives Disease in Burkitt Lymphoma.

Hüllein J, Słabicki M, Rosolowski M, Jethwa A, Habringer S, Tomska K, Kurilov R, Lu J, Scheinost S, Wagener R, Huang Z, Lukas M, Yavorska O, Helfrich H, Scholtysik R, Bonneau K, Tedesco D, Küppers R, Klapper W, Pott C, Stilgenbauer S, Burkhardt B, Löffler M, Trümper LH, Hummel M, Brors B, Zapatka M, Siebert R, Kreuz M, Keller U, Huber W, Zenz T.

Cancer Res. 2019 Jun 15;79(12):3125-3138. doi: 10.1158/0008-5472.CAN-18-3438. Epub 2019 Apr 18.

PMID:
31000522
21.

PiggyBac transposon tools for recessive screening identify B-cell lymphoma drivers in mice.

Weber J, de la Rosa J, Grove CS, Schick M, Rad L, Baranov O, Strong A, Pfaus A, Friedrich MJ, Engleitner T, Lersch R, Öllinger R, Grau M, Menendez IG, Martella M, Kohlhofer U, Banerjee R, Turchaninova MA, Scherger A, Hoffman GJ, Hess J, Kuhn LB, Ammon T, Kim J, Schneider G, Unger K, Zimber-Strobl U, Heikenwälder M, Schmidt-Supprian M, Yang F, Saur D, Liu P, Steiger K, Chudakov DM, Lenz G, Quintanilla-Martinez L, Keller U, Vassiliou GS, Cadiñanos J, Bradley A, Rad R.

Nat Commun. 2019 Mar 29;10(1):1415. doi: 10.1038/s41467-019-09180-3.

22.

Non-Hodgkin Lymphoma Secondary to Hodgkin Lymphoma in an Adult Patient With Nijmegen Breakage Syndrome.

Braitsch K, Vag T, Slotta-Huspenina J, Keller U.

Hemasphere. 2018 Oct;2(5):e140. doi: 10.1097/HS9.0000000000000140. Epub 2018 Oct 2. No abstract available.

23.

Side Effects of CXC-Chemokine Receptor 4-Directed Endoradiotherapy with Pentixather Before Hematopoietic Stem Cell Transplantation.

Maurer S, Herhaus P, Lippenmeyer R, Hänscheid H, Kircher M, Schirbel A, Maurer HC, Buck AK, Wester HJ, Einsele H, Grigoleit GU, Keller U, Lapa C.

J Nucl Med. 2019 Oct;60(10):1399-1405. doi: 10.2967/jnumed.118.223420. Epub 2019 Mar 8.

PMID:
30850502
24.

SDF1α-induced chemotaxis of JAK2-V617F-positive cells is dependent on Bruton tyrosine kinase and its downstream targets PI3K/AKT, PLCγ1 and RhoA.

Nimmagadda SC, Frey S, Müller P, Wolleschak D, Weinert S, Keller U, Edelmann B, Fischer T.

Haematologica. 2019 Jul;104(7):e288-e292. doi: 10.3324/haematol.2018.201921. Epub 2019 Feb 14. No abstract available.

25.

An unstabilized femtosecond semiconductor laser for dual-comb spectroscopy of acetylene.

Nürnberg J, Alfieri CGE, Chen Z, Waldburger D, Picqué N, Keller U.

Opt Express. 2019 Feb 4;27(3):3190-3199. doi: 10.1364/OE.27.003190.

PMID:
30732344
26.

Tightly locked optical frequency comb from a semiconductor disk laser.

Waldburger D, Mayer AS, Alfieri CGE, Nürnberg J, Johnson AR, Ji X, Klenner A, Okawachi Y, Lipson M, Gaeta AL, Keller U.

Opt Express. 2019 Feb 4;27(3):1786-1797. doi: 10.1364/OE.27.001786.

PMID:
30732226
27.

From the Representativeness of Sampled Odors to an Olfactive Camera.

Chaintreau A, Keller U, Zellner B, Nguy K, Leocata S, Begnaud F.

J Agric Food Chem. 2019 Feb 13;67(6):1711-1718. doi: 10.1021/acs.jafc.8b06383. Epub 2019 Feb 4.

PMID:
30661361
28.

Sub-150-fs pulses from an optically pumped broadband modelocked integrated external-cavity surface emitting laser.

Alfieri CGE, Waldburger D, Nürnberg J, Golling M, Keller U.

Opt Lett. 2019 Jan 1;44(1):25-28. doi: 10.1364/OL.44.000025.

PMID:
30645536
29.

Programmable pulse shaping for time-gated amplifiers.

Pupeikis J, Bigler N, Hrisafov S, Phillips CR, Keller U.

Opt Express. 2019 Jan 7;27(1):175-184. doi: 10.1364/OE.27.000175.

PMID:
30645365
30.

Clinical presentation and characteristics of lymphoma in the head and neck region.

Storck K, Brandstetter M, Keller U, Knopf A.

Head Face Med. 2019 Jan 3;15(1):1. doi: 10.1186/s13005-018-0186-0.

31.

High-power OPCPA generating 1.7 cycle pulses at 2.5 µm.

Bigler N, Pupeikis J, Hrisafov S, Gallmann L, Phillips CR, Keller U.

Opt Express. 2018 Oct 1;26(20):26750-26757. doi: 10.1364/OE.26.026750.

PMID:
30469755
32.

Cancer clinical trials - Survey evaluating patient participation and acceptance in a university-based Comprehensive Cancer Center (CCC).

Kessel KA, Vogel MME, Kessel C, Bier H, Biedermann T, Friess H, Herschbach P, von Eisenhart-Rothe R, Meyer B, Kiechle M, Keller U, Peschel C, Bassermann F, Schmid R, Schwaiger M, Combs SE.

Clin Transl Radiat Oncol. 2018 Oct 4;13:44-49. doi: 10.1016/j.ctro.2018.10.001. eCollection 2018 Nov.

33.

Comparison of actinomycin peptide synthetase formation in Streptomyces chrysomallus and Streptomyces antibioticus.

Crnovčić I, Lang M, Ortel I, Süssmuth RD, Keller U.

J Basic Microbiol. 2019 Feb;59(2):148-157. doi: 10.1002/jobm.201800244. Epub 2018 Sep 20.

PMID:
30238507
34.

PET imaging of chemokine receptor CXCR4 in patients with primary and recurrent breast carcinoma.

Vag T, Steiger K, Rossmann A, Keller U, Noske A, Herhaus P, Ettl J, Niemeyer M, Wester HJ, Schwaiger M.

EJNMMI Res. 2018 Sep 6;8(1):90. doi: 10.1186/s13550-018-0442-0.

35.

Multipulse instabilities of a femtosecond SESAM-modelocked VECSEL.

Waldburger D, Alfieri CGE, Link SM, Meinecke S, Jaurigue LC, Lüdge K, Keller U.

Opt Express. 2018 Aug 20;26(17):21872-21886. doi: 10.1364/OE.26.021872.

PMID:
30130890
36.

Comparison of the dose-response pharmacodynamic profiles of detemir and glargine in severely obese patients with type 2 diabetes: A single-blind, randomised cross-over trial.

Bilz S, Flückiger M, Meienberg F, Falconnier C, Keller U, Puder JJ.

PLoS One. 2018 Aug 16;13(8):e0202007. doi: 10.1371/journal.pone.0202007. eCollection 2018.

37.

CXCR4-directed theranostics in oncology and inflammation.

Kircher M, Herhaus P, Schottelius M, Buck AK, Werner RA, Wester HJ, Keller U, Lapa C.

Ann Nucl Med. 2018 Oct;32(8):503-511. doi: 10.1007/s12149-018-1290-8. Epub 2018 Aug 13. Review.

38.

Orientation-dependent stereo Wigner time delay and electron localization in a small molecule.

Vos J, Cattaneo L, Patchkovskii S, Zimmermann T, Cirelli C, Lucchini M, Kheifets A, Landsman AS, Keller U.

Science. 2018 Jun 22;360(6395):1326-1330. doi: 10.1126/science.aao4731.

PMID:
29930132
39.

Gas-lens effect in kW-class thin-disk lasers.

Diebold A, Saltarelli F, Graumann IJ, Saraceno CJ, Phillips CR, Keller U.

Opt Express. 2018 May 14;26(10):12648-12659. doi: 10.1364/OE.26.012648.

PMID:
29801303
40.

REGGAE: a novel approach for the identification of key transcriptional regulators.

Kehl T, Schneider L, Kattler K, Stöckel D, Wegert J, Gerstner N, Ludwig N, Distler U, Schick M, Keller U, Tenzer S, Gessler M, Walter J, Keller A, Graf N, Meese E, Lenhof HP.

Bioinformatics. 2018 Oct 15;34(20):3503-3510. doi: 10.1093/bioinformatics/bty372.

41.

Author Correction: Watt-level 10-gigahertz solid-state laser enabled by self-defocusing nonlinearities in an aperiodically poled crystal.

Mayer AS, Phillips CR, Keller U.

Nat Commun. 2018 Apr 11;9(1):1492. doi: 10.1038/s41467-018-03816-6.

42.

Autologous Stem Cell Transplantation for Patients with Early Progression of Follicular Lymphoma: A Follow-Up Study of 2 Randomized Trials from the German Low Grade Lymphoma Study Group.

Jurinovic V, Metzner B, Pfreundschuh M, Schmitz N, Wandt H, Keller U, Dreger P, Dreyling M, Hiddemann W, Unterhalt M, Hoster E, Weigert O.

Biol Blood Marrow Transplant. 2018 Jun;24(6):1172-1179. doi: 10.1016/j.bbmt.2018.03.022. Epub 2018 Mar 29.

43.

Decoupling phase-matching bandwidth and interaction geometry using non-collinear quasi-phase-matching gratings.

Bigler N, Pupeikis J, Hrisafov S, Gallmann L, Phillips CR, Keller U.

Opt Express. 2018 Mar 5;26(5):6036-6045. doi: 10.1364/OE.26.006036.

PMID:
29529799
44.

Anisotropic photoemission time delays close to a Fano resonance.

Cirelli C, Marante C, Heuser S, Petersson CLM, Galán ÁJ, Argenti L, Zhong S, Busto D, Isinger M, Nandi S, Maclot S, Rading L, Johnsson P, Gisselbrecht M, Lucchini M, Gallmann L, Dahlström JM, Lindroth E, L'Huillier A, Martín F, Keller U.

Nat Commun. 2018 Mar 6;9(1):955. doi: 10.1038/s41467-018-03009-1.

45.

Diabetiker werden immer älter – was hat das für Konsequenzen für die Behandlung?

Keller U.

Ther Umsch. 2017;74(8):454-461. doi: 10.1024/0040-5930/a000940. Review. German. No abstract available.

PMID:
29461146
46.

Nonadiabatic effects in electronic and nuclear dynamics.

Bircher MP, Liberatore E, Browning NJ, Brickel S, Hofmann C, Patoz A, Unke OT, Zimmermann T, Chergui M, Hamm P, Keller U, Meuwly M, Woerner HJ, Vaníček J, Rothlisberger U.

Struct Dyn. 2018 Jan 9;4(6):061510. doi: 10.1063/1.4996816. eCollection 2017 Nov. Review.

47.

Preface to Swiss National Center of Competence in Research: Molecular Ultrafast Science and Technology.

Feurer T, Keller U.

Struct Dyn. 2018 Jan 8;4(6):061401. doi: 10.1063/1.5018454. eCollection 2017 Nov. No abstract available.

48.

Charge migration and charge transfer in molecular systems.

Wörner HJ, Arrell CA, Banerji N, Cannizzo A, Chergui M, Das AK, Hamm P, Keller U, Kraus PM, Liberatore E, Lopez-Tarifa P, Lucchini M, Meuwly M, Milne C, Moser JE, Rothlisberger U, Smolentsev G, Teuscher J, van Bokhoven JA, Wenger O.

Struct Dyn. 2017 Dec 27;4(6):061508. doi: 10.1063/1.4996505. eCollection 2017 Nov. Review.

49.

Ketonization of Proline Residues in the Peptide Chains of Actinomycins by a 4-Oxoproline Synthase.

Semsary S, Crnovčić I, Driller R, Vater J, Loll B, Keller U.

Chembiochem. 2018 Apr 4;19(7):706-715. doi: 10.1002/cbic.201700666. Epub 2018 Feb 15.

PMID:
29327817
50.

Azacitidine combined with the selective FLT3 kinase inhibitor crenolanib disrupts stromal protection and inhibits expansion of residual leukemia-initiating cells in FLT3-ITD AML with concurrent epigenetic mutations.

Garz AK, Wolf S, Grath S, Gaidzik V, Habringer S, Vick B, Rudelius M, Ziegenhain C, Herold S, Weickert MT, Smets M, Peschel C, Oostendorp RAJ, Bultmann S, Jeremias I, Thiede C, Döhner K, Keller U, Götze KS.

Oncotarget. 2017 Oct 16;8(65):108738-108759. doi: 10.18632/oncotarget.21877. eCollection 2017 Dec 12.

Supplemental Content

Loading ...
Support Center